These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11027188)

  • 1. Computational model for effects of ligand/receptor binding properties on interleukin-2 trafficking dynamics and T cell proliferation response.
    Fallon EM; Lauffenburger DA
    Biotechnol Prog; 2000; 16(5):905-16. PubMed ID: 11027188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding by the IL-2 receptor is modulated by intracellular determinants of the IL-2 receptor beta-chain.
    Goldsmith MA; Amaral MC; Greene WC
    J Immunol; 1995 Mar; 154(5):2033-40. PubMed ID: 7868880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parsing the effects of binding, signaling, and trafficking on the mitogenic potencies of granulocyte colony-stimulating factor analogues.
    Sarkar CA; Lowenhaupt K; Wang PJ; Horan T; Lauffenburger DA
    Biotechnol Prog; 2003; 19(3):955-64. PubMed ID: 12790662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect.
    Rao BM; Driver I; Lauffenburger DA; Wittrup KD
    Mol Pharmacol; 2004 Oct; 66(4):864-9. PubMed ID: 15385640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth.
    Rao BM; Driver I; Lauffenburger DA; Wittrup KD
    Biochemistry; 2005 Aug; 44(31):10696-701. PubMed ID: 16060678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alpha chain of the IL-2 receptor determines the species specificity of high-affinity IL-2 binding.
    Liu KD; Greene WC; Goldsmith MA
    Cytokine; 1996 Aug; 8(8):613-21. PubMed ID: 8894436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of T cell proliferation: a mathematical model and data analysis.
    Borisova LR; Andreev SG; Kuznetsov VA
    Membr Cell Biol; 1998; 12(1):111-9. PubMed ID: 9829264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical model of T lymphocyte proliferation controlled by interleukin-2 internalization.
    Borisova LR; Kuznetsov VA
    Membr Cell Biol; 1997; 11(2):259-67. PubMed ID: 9354404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role of metalloproteinase in cancer-mediated immunosuppression.
    Sheu BC; Hsu SM; Ho HN; Lien HC; Huang SC; Lin RH
    Cancer Res; 2001 Jan; 61(1):237-42. PubMed ID: 11196168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling.
    Conrad DM; Hanniman EA; Watson CL; Mader JS; Hoskin DW
    J Cell Biochem; 2004 May; 92(2):387-99. PubMed ID: 15108363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
    Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
    Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review.
    Olejniczak K; Kasprzak A
    Med Sci Monit; 2008 Oct; 14(10):RA179-89. PubMed ID: 18830208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of interleukin-15 receptor alpha: trans-presentation, receptor component, or both?
    Schluns KS; Stoklasek T; Lefrançois L
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1567-71. PubMed ID: 15896666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the proliferative response of T cells to IL-2 and IL-4.
    Burke MA; Morel BF; Oriss TB; Bray J; McCarthy SA; Morel PA
    Cell Immunol; 1997 May; 178(1):42-52. PubMed ID: 9184697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy.
    Liu S; Riley J; Rosenberg S; Parkhurst M
    J Immunother; 2006; 29(3):284-93. PubMed ID: 16699371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased endosomal sorting of ligand to recycling enhances potency of an interleukin-2 analog.
    Fallon EM; Liparoto SF; Lee KJ; Ciardelli TL; Lauffenburger DA
    J Biol Chem; 2000 Mar; 275(10):6790-7. PubMed ID: 10702236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of high-affinity IL-2-IL-2R interaction for T cell anergy induction.
    Hayashi RJ; Kanagawa O
    Int Immunol; 2006 May; 18(5):645-51. PubMed ID: 16574670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation.
    Pahwa R; McCloskey TW; Aroniadis OC; Strbo N; Krishnan S; Pahwa S
    J Infect Dis; 2006 Mar; 193(6):879-87. PubMed ID: 16479523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
    J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2.
    Cho JH; Boyman O; Kim HO; Hahm B; Rubinstein MP; Ramsey C; Kim DM; Surh CD; Sprent J
    J Exp Med; 2007 Aug; 204(8):1787-801. PubMed ID: 17664294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.